A006 DPI

· Amphastar Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for A006 DPI, covering 2017-04-19 to 2017-04-19. Get the full timeline:

Most recent: Clinical Trial Update: Dose-Ranging Study of A006 DPI, in Adult Asthma Patients [Phase 2]